絞り込み

17092

広告

「"Rutkowski P "[Author]」の検索結果

365件中 81件~100件表示    検索結果をPubMedで見る PubMedで見る

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.

Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib.

Differences in recurrence and survival of extremity liposarcoma subtypes.

Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.

Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.

Immunotherapy of melanoma.

Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST).

IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma.

The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'.

Treatment of the urinary tract diseases in the 16th-century work Cieplice (Thermal Springs) by Wojciech Oczko (1537-1599).

Nobel Prize Winners Who Contributed To Transplantation.

Adjuvant vemurafenib in resected, BRAFmutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

ECCO essential requirements for quality cancer care: Melanoma.

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST).

Improvement of Blood Pressure Control in Renal Transplant Recipients-Retrospective Longitudinal Study.

Treatment of Hypertension in Renal Transplant Recipients in Four Independent Cross-Sectional Analyses.

Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).

Coordinated expression and genetic polymorphisms in Grainyhead-like genes in human non-melanoma skin cancers.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります